Hypoxic cell radiosensitizers as potential adjuvants to conventional chemotherapy for the treatment of cancer.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004734:Energy Metabolism / Q000187:drug effects; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D009422:Nervous System Diseases / Q000139:chemically induced; D009574:Nitro Compounds / Q000378:metabolism; D010084:Oxidation-Reduction; D010100:Oxygen / Q000502:physiology; D011838:Radiation-Sensitizing Agents / Q000009:adverse effects / Q000627:therapeutic use*; D013438:Sulfhydryl Compounds / Q000494:pharmacology
D000970:Antineoplastic Agents; D009574:Nitro Compounds; D011838:Radiation-Sensitizing Agents; D013438:Sulfhydryl Compounds; D010100:Oxygen